FDA approves Aurobindo's Sertraline Hydrochloride

Aurobindo Pharma has received tentative approval from the US Food & Drug Administration (USFDA) for Sertraline Hydrochloride tablets.

According to a release issued by Aurobindo Pharma to the BSE toady, the USFDA approval is for tablets of  of 25 mg (base), 50 mg (base) and 100 mg (base).